Ignite Creation Date:
2025-12-25 @ 12:28 AM
Ignite Modification Date:
2026-01-11 @ 3:03 AM
Study NCT ID:
NCT03301467
Status:
COMPLETED
Last Update Posted:
2025-03-13
First Post:
2017-09-22
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Controlled Trial Evaluating Avacopan in C3 Glomerulopathy
Sponsor:
Amgen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-09-29
Start Date Type:
ACTUAL
Primary Completion Date:
2021-03-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-10-27
Completion Date Type:
ACTUAL
First Submit Date:
2017-09-22
First Submit QC Date:
None
Study First Post Date:
2017-10-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-05-19
Results First Submit QC Date:
None
Results First Post Date:
2022-10-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-04
Last Update Post Date:
2025-03-13
Last Update Post Date Type:
ACTUAL